0000914190-19-000164.txt : 20190517 0000914190-19-000164.hdr.sgml : 20190517 20190517160539 ACCESSION NUMBER: 0000914190-19-000164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190515 FILED AS OF DATE: 20190517 DATE AS OF CHANGE: 20190517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FINKELSTEIN J J CENTRAL INDEX KEY: 0001125610 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15070 FILM NUMBER: 19835650 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-208-9191 MAIL ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-05-15 0000707511 REGENERX BIOPHARMACEUTICALS INC RGRX 0001125610 FINKELSTEIN J J C/O REGENERX BIOPHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 470 ROCKVILLE MD 20850 1 1 0 0 President and CEO Common Stock 1637991 D Stock Option (right to buy) .21 2021-03-25 Common Stock 500000 500000 D Stock Option (right to buy) .36 2022-06-30 Common Stock 500000 500000 D Stock Option (right to buy) .64 2023-03-16 Common Stock 200000 200000 D Stock Option (right to buy) .28 2027-09-01 Common Stock 150000 150000 D Stock Option (right to buy) .21 2028-07-17 Common Stock 250000 250000 D Stock Option (right to buy) .21 2019-05-15 4 A 0 650000 0 A 2029-05-15 Common Stock 650000 650000 D Convertible Promissory Note (right to buy) .12 2019-02-27 2024-02-27 Common Stock 104167 12500.00 D Convertible Promissory Note (right to buy) .12 2019-05-13 2024-05-13 Common Stock 104167 12500.00 D Common Stock Warrant (right to buy) .18 2019-08-27 2024-02-27 Common Stock 78125 78125 D Common Stock Warrant (right to buy) .18 2019-11-13 2024-05-13 Common Stock 78125 78125 D 100% vested. 37,500 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20. 62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21. 162,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22. /s/ Andrew Nick as Attorney-in-Fact for J.J. Finkelstein pursuant to Power of Attorney previously filed. 2019-05-17